Sodium Bicarbonate in 5% Dextrose Injection recalled over sterility concerns

Recall date

July 7, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

SterRx, LLC recalls Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL Single Dose bag, packaged…

Recall number

D-0930-2023

FDA classification

Class II

Brand / firm

SterRx, LLC

Sold / distributed

Nationwide in the USA

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL Single Dose bag, packaged in 1000 mL x 6 units per case, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-326-01.